João Pedro de Magalhães | Longevity Drug Discovery

At Ending Age-Related Diseases 2019, João Pedro de Magalhães of the University of Liverpool discussed the genetic basis of aging and the difficulties inherent in drug discovery. He also brought up the Hallmarks of Aging, the difference between humans and animals, senescent cells, and future strategies to discover therapies that allow human beings to live longer.

►Subscribe for more:
►This video is presented by LEAF. Please support our work by becoming a Lifespan Hero:
#Aging #Science #Longevity

gerontology,longevity,lifespan,Life Extension Advocacy Foundation,LEAF,Ending Age-Related Diseases,XPRIZE,rejuvenation,rejuvenation biotechnology,research,biotechnology,life extension,conference,investment,investors,researchers,Aging,Ageing,Health Care,Healthspan,Cooper Union,New York City,NYC,drug discovery,genetics,mouse studies,Hallmarks of Aging,João Pedro de Magalhães,University of Liverpool,